Document Detail

Exercise and zoledronic acid on lipid profile and bone remodeling in ovariectomized rats: a paradoxical negative association?
MedLine Citation:
PMID:  20229125     Owner:  NLM     Status:  MEDLINE    
Exercise (EXE) and amino-bisphosphonates (BP) are both considered as useful strategies in the prevention of post-menopausal bone loss. Exercise reduces lipid levels, and BP may induce increase in high-density lipoprotein cholesterol (HDL-C). We hypothesized that combined effects of BP and exercise would produce a better improvement of lipid profile. We studied the specific and combined effects of zoledronic acid (Z) and EXE on lipid profile and bone remodeling in mature ovariectomized (OVX) rats. Six-month old female rats were randomly assigned to either a sham-ovx group (n = 12) or one of four OVX groups (n = 12): vehicle-treated sedentary (OVX); OVX + EXE (OVX-E, running on a treadmill for 12 weeks); OVX + Z (20 microg/kg, i.v.), (OVX-Z); OVX + Z+EXE (OVX-ZE). Total cholesterol (TC), HDL-C and bone remodeling markers were measured at baseline and at the end of the study. We demonstrated that both Z and EXE prevented the increase in bone resorption resulting from OVX, and individually improved the atherosclerotic risk index. Therapy with Z resulted in significant increase (39.00 +/- 0.03 vs. 53.6 +/- 0.01 mg/dl; +37.4%, P < 0.05) in serum concentration of HDL-C and a non significant decrease in TC (135.30 +/- 0.03 vs. 144.80 +/- 0.05 mg/dl; -5.8%) in the OVX-Z group compared to the OVX group. Post-menopausal women have elevated risk of CVD and bone resorption, hence, these data ultimately demonstrate (except for the elevated ratio in the combined group) that exercise and zoledronic acid are useful in minimizing the impact of these two processes in women and the combination of the two may be clinically relevant.
E Lespessailles; C Jaffr?; G Y Rochefort; E Doll?ans; C L Benhamou; D Courteix
Related Documents :
8543695 - Congenital nevomelanocytic nevi: proportionate area expansion during infancy and early ...
8342465 - Vitamin d status and hypocalcemic response to protamine in exercised and non-exercised ...
10944575 - Biological time and in vivo research: a field guide to pitfalls.
19453205 - Exercise and bone mass in adults.
9558685 - Efficacy of ventricular rate stabilization by right ventricular pacing during atrial fi...
1527735 - Comparative effects of a potassium channel blocking drug, uk-68,798, and a specific bra...
Publication Detail:
Type:  Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-03-13
Journal Detail:
Title:  Lipids     Volume:  45     ISSN:  1558-9307     ISO Abbreviation:  Lipids     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-03-25     Completed Date:  2010-06-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0060450     Medline TA:  Lipids     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  337-44     Citation Subset:  IM    
UMR-S658 INSERM, CHR ORLEANS Porte Madeleine, BP 2439, 45032 Orleans Cedex 1, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Markers / blood,  metabolism
Bone Density Conservation Agents / pharmacology
Bone Remodeling* / drug effects,  physiology
Diphosphonates / pharmacology*
Imidazoles / pharmacology*
Lipid Metabolism / drug effects,  physiology
Lipids / blood*
Physical Conditioning, Animal / physiology*
Rats, Wistar
Tumor Necrosis Factor-alpha / blood
Reg. No./Substance:
0/Biological Markers; 0/Bone Density Conservation Agents; 0/Diphosphonates; 0/Imidazoles; 0/Lipids; 0/Tumor Necrosis Factor-alpha; 118072-93-8/zoledronic acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pitavastatin Reduces Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands in Hypercholest...
Next Document:  Control of infection by pyroptosis and autophagy: role of TLR and NLR.